Endometrial Cancer Trial, Recruiting NCT06527456 Sponsor: Centre Hospitalier Intercommunal Creteil Condition: Endometrial Cancer
Back to Endometrial Cancer

Endometrial Cancer Trial, Recruiting

NCT06527456
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Women aged 25 to 65 who live in the Île-de-France region of France
  • Women who are eligible for cervical cancer screening — meaning they have not had a hysterectomy (removal of the uterus) and are not currently being monitored for a pre-cancerous or cancerous condition of the cervix
  • Women whose registered treating doctor (general practitioner) works within a specific local healthcare network in the UPEC area, and who have officially named that doctor as their primary care provider
  • Women who are covered by a French social security (health insurance) scheme

Who may not be able to join:

  • People who are already taking part in another study related to cervical cancer screening
  • People who are excluded from the organised cervical cancer screening programme — for example, because they have had a hysterectomy
  • People who do not wish to participate in the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 0633085225

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Centre Hospitalier Intercommunal Creteil
Registry
ClinicalTrials.gov
Start date
21 January 2026
Est. completion
1 August 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

screening participation rate

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov